Novavax Inc (NASDAQ:NVAX) announced it will present on its lead COVID-19 vaccine candidate at the 2020 World Vaccine Congress Washington scheduled for this week.
It will also present its influenza and respiratory syncytial virus jabs, while the main focus will be to share expertise and the latest research related to the pandemic and vaccine development to address global health.
The US firm is set to start late-stage trials for NVX-CoV2373 in the UK, enrolling up to 10,000 participants aged 18-84 over the next six weeks, with half receiving the formulation and half receiving a placebo.
Up to 400 volunteers will receive both Novavax’s candidate and a seasonal flu vaccine to see if the combination works.
Data for from the Phase II of clinical trials are expected in the fourth quarter of 2020.
J&J said last week a single dose of its formulation produced a strong immune response in phase II of trials.
Story by ProactiveInvestors
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.